BIOA · Categories · Form 4

BIOA - SEC Form 4 insider transactions

BioAge Labs Inc. (BIOA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BIOA

• 2d
  Chief Financial Officer Goldstein Dov A Md exercised 3,542 shares at a strike of $4.38, increasing direct ownership by 11% to 36,575 units (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 24d
  SEC Form 4 filed by Rubin Paul D

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 54d
  Chief Medical Officer Rubin Paul D exercised 7,433 shares at a strike of $4.77 and sold $150,890 worth of shares (7,433 units at $20.30) (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 54d
  Chief Financial Officer Goldstein Dov A Md exercised 3,542 shares at a strike of $4.38, increasing direct ownership by 12% to 33,033 units (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 66d
  SEC Form 4 filed by Chief Medical Officer Rubin Paul D

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 66d
  SEC Form 4 filed by Chief Operating Officer Morgen Eric

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 66d
  SEC Form 4 filed by Chief Financial Officer Goldstein Dov A Md

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 66d
  SEC Form 4 filed by Chief Executive Officer Fortney Kristen

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 66d
  SEC Form 4 filed by Principal Accounting Officer Barton Shane

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 82d
  Chief Medical Officer Rubin Paul D exercised 7,433 shares at a strike of $4.77 and sold $139,369 worth of shares (7,433 units at $18.75) (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 82d
  Chief Financial Officer Goldstein Dov A Md exercised 3,541 shares at a strike of $4.38, increasing direct ownership by 14% to 29,491 units (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 95d
  Chief Financial Officer Goldstein Dov A Md exercised 3,542 shares at a strike of $4.38, increasing direct ownership by 16% to 25,950 units (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 101d
  Chief Financial Officer Goldstein Dov A Md exercised 27,000 shares at a strike of $8.39 and sold $531,828 worth of shares (27,000 units at $19.70) (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 101d
  Chief Executive Officer Fortney Kristen sold $4,223,036 worth of shares (233,107 units at $18.12), decreasing direct ownership by 19% to 976,949 units (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 110d
  Chief Medical Officer Rubin Paul D exercised 7,433 shares at a strike of $4.77 and sold $95,490 worth of shares (7,433 units at $12.85) (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 136d
  Chief Medical Officer Rubin Paul D exercised 18,000 shares at a strike of $6.57 and sold $216,000 worth of shares (18,000 units at $12.00) (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 142d
  Chief Medical Officer Rubin Paul D exercised 68,897 shares at a strike of $4.11 and sold $701,909 worth of shares (68,897 units at $10.19) (SEC Form 4)

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 259d
  SEC Form 4 filed by Director Pande Vijay Satyanand

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 321d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 321d
  SEC Form 4 filed by Director Healy James

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 321d
  SEC Form 4 filed by Director Enright Patrick G

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 321d
  SEC Form 4 filed by Director Davidson Michael H.

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 321d
  SEC Form 4 filed by Director Garnier Jean Pierre

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 425d
  Amendment: SEC Form 4 filed by Chief Operating Officer Morgen Eric

  4/A - BioAge Labs, Inc. (0001709941) (Issuer)
• 430d
  SEC Form 4 filed by Chief Medical Officer Rubin Paul D

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 430d
  SEC Form 4 filed by Chief Operating Officer Morgen Eric

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 430d
  SEC Form 4 filed by Chief Financial Officer Goldstein Dov A Md

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 430d
  SEC Form 4 filed by Chief Executive Officer Fortney Kristen

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 430d
  SEC Form 4 filed by Principal Accounting Officer Barton Shane

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 492d
  SEC Form 4 filed by Principal Accounting Officer Barton Shane

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 576d
  SEC Form 4 filed by Chief Executive Officer Fortney Kristen

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 576d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 576d
  SEC Form 4 filed by Director Davidson Michael H.

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 576d
  SEC Form 4 filed by Director Garnier Jean Pierre

  4 - BioAge Labs, Inc. (0001709941) (Issuer)
• 576d
  SEC Form 4 filed by Chief Operating Officer Morgen Eric

  4 - BioAge Labs, Inc. (0001709941) (Issuer)

Other BIOA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends